PRISTIQ® Principal Display Panel (desvenlafaxine succinate)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 50 mg Tablet Blister Pack

NDC 0008-1211-50
Pristiq®
(desvenlafaxine)

Extended-Release
Tablets
50 mg*

*Equivalent to 76 mg
desvenlafaxine succinate
MADE IN SINGAPORE

PAA041479

Wyeth® Phila., PA 19101

PRINCIPAL DISPLAY PANEL - 50 mg Tablet Blister Pack Carton

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer
NDC 0008-1211-50

10 Redipak® Blister
Strips of 10 Tablets

Pristiq®
(desvenlafaxine)
Extended-Release Tablets

50 mg*

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer
NDC 0008-1211-30

Pristiq®
(desvenlafaxine)
Extended-Release Tablets

50 mg*

Unit of Use
30 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 100 mg Tablet Bottle Label

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer
NDC 0008-1222-30

Pristiq®
(desvenlafaxine)
Extended-Release Tablets

100 mg*

Unit of Use
30 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 100 mg Tablet Blister Pack

NDC 0008-1222-50
Pristiq®
(desvenlafaxine)

Extended-Release
Tablets
100 mg*

*Equivalent to 152 mg
desvenlafaxine succinate
MADE IN SINGAPORE

PAA041470

Wyeth® Phila., PA 19101

PRINCIPAL DISPLAY PANEL - 100 mg Tablet Blister Pack Carton

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer
NDC 0008-1222-50

10 Redipak® Blister
Strips of 10 Tablets

Pristiq®
(desvenlafaxine)
Extended-Release Tablets

100 mg*

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 25 mg Tablet Bottle Label

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer
NDC 0008-1210-30

Pristiq®
(desvenlafaxine)
Extended-Release Tablets

25 mg*

Unit of Use
30 Tablets
Rx only

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRISTIQ® Quick Finder

Ingredient & Allergen Checker
Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.

If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All